Controlled, Double-Blind, Randomised, Dose-Ranging Study on the Prevention of VTE (venous thromboembolism) in Patients Undergoing Elective Total Hip Replacement- ODIXa-HIP2 Study BAY 59-7939 [rivaroxaban].
Phase of Trial: Phase II
Latest Information Update: 12 May 2009
At a glance
- Drugs Enoxaparin sodium; Rivaroxaban
- Indications Deep vein thrombosis; Pulmonary embolism; Thromboembolism
- Focus Therapeutic Use
- Acronyms ODIXa-HIP2 Study
- Sponsors Bayer
- 12 May 2009 Actual initiation date (Jan 2004) added as reported by ClinicalTrials.gov.
- 12 May 2009 Actual end date (Sep 2004) added as reported by ClinicalTrials.gov.
- 27 Nov 2006 New trial record.